Advertisement
Among patients with mild-to-moderate acute traumatic brain injury

Tranexamic Acid Within Three Hours Cuts Some TBI Deaths

0
Patients with mild-to-moderate injury treated with tranexamic acid had reduced risk for head injury-related death
For patients with chronic obstructive pulmonary disease

CHEST: Metoprolol Does Not Cut Time to COPD Exacerbation

0
Trial stopped early due to futility with respect to primary end point and safety concerns
The over-the-counter heartburn drug Zantac (ranitidine) has been recalled in the United States and Canada by French drug maker Sanofi.

Zantac Recalled by Sanofi

0
FDA has warned that some versions of the drug contain low levels of N-nitrosodimethylamine
In clinical guidelines published online Oct. 22 in the Annals of Internal Medicine

Recommendations Updated for Nonvariceal Upper GI Bleeding

0
Guidelines address preendoscopic, endoscopic, and pharmacologic management
For patients with metastatic breast cancer

Patient Cost Responsibility Up for Guideline-Discordant Care

0
Guideline-discordant tx linked to $1,841 higher patient costs in first year in metastatic breast cancer
For patients with knee osteoarthritis

Physical Therapy, Lifestyle Advice Underused in Knee OA

0
2007 to 2015 saw increase in use of NSAID prescriptions from orthopedists, primary care doctors
Among individuals aged 66 years and older

Suicide Risk Up With ARB Exposure Versus ACEI Exposure

0
Risk for suicide increased with angiotensin receptor blockers among individuals aged 66 years and older
Longer use of estrogen hormone therapy is associated with higher cognitive status in late life

Extended Estrogen Therapy Aids Late-Life Cognition

0
Benefit seen especially in older women and women initiating treatment within five years of menopause
For the 2018 to 2019 school year

CDC: Coverage 94.7 Percent for Two Doses of MMR in 2018 to 2019

0
2.8 percent of kindergartners were not up to date with MMR vaccination and did not have exemption
A shipment of baby powder has been recalled by Johnson & Johnson after U.S. authorities found asbestos in it.

Johnson & Johnson Recalls Baby Powder Due to Presence of Asbestos

0
This is the first time Johnson & Johnson has pulled its baby powder from the market